BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 9821235)

  • 41. Role of nebulized ipratropium bromide in acute exacerbation of early chronic obstructive airway disease.
    Bharthwal MS
    J Assoc Physicians India; 2000 Mar; 48(3):363. PubMed ID: 11229133
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical aspects, diagnosis and treatment of obstructive lung diseases among the population of Afghanistan].
    Malen'kiĭ VP; Samadi G
    Ter Arkh; 1988; 60(8):68-71. PubMed ID: 3227481
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Steroid response after long-term treatment with oral N-acetylcysteine in patients with chronic obstructive bronchitis].
    Evald T; Hansen M; Balsløv S; Brorson-Riis L; Hansen NC; Maltbaek N; Thorshauge H
    Ugeskr Laeger; 1989 Nov; 151(46):2076-8. PubMed ID: 2688231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of anticholinergic therapy on myocardial reserve dynamics in patients with chronic obstructive bronchitis].
    Nepriadkina IV; Khmeleva AV; Polivoda SN
    Lik Sprava; 2001; (5-6):174-5. PubMed ID: 11881364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Atrovent administered by inhalation on pulmonary mechanics in patients with obstructive lung disease [proceedings].
    Koch G
    Scand J Respir Dis Suppl; 1979; 103():206-7. PubMed ID: 155300
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of inhalational bronchodilator treatment during noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations.
    Mukhopadhyay A; Dela Pena E; Wadden B; Procyshyn M; Keang Lim T
    J Crit Care; 2009 Sep; 24(3):474.e1-5. PubMed ID: 19664528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Current broncholytic and expectorant therapy of patients with chronic nonspecific lung diseases].
    Solopov VN; Kolganova NA; Chuchalin AG
    Ter Arkh; 1987; 59(12):96-9. PubMed ID: 2965833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of domiciliary nebulizers in managing patients with severe COPD.
    Eiser N; Angus K; McHale S
    Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of ipratropium bromide on airway and pulmonary muscarinic receptors in a rat model of chronic obstructive pulmonary disease.
    Yao W; Wang G; Zhu H; Sun Y; Zhao M
    Chin Med J (Engl); 2001 Jan; 114(1):80-3. PubMed ID: 11779443
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary diseases.
    Gupta RK; Chhabra SK
    Indian J Chest Dis Allied Sci; 2002; 44(3):165-72. PubMed ID: 12206475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical comparison of Atrovent and a placebo in patients with chronic obstructive lung diseases].
    Lien JT
    Tidsskr Nor Laegeforen; 1980 Jul; 100(19-21):1193-5. PubMed ID: 6448492
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of oral doxofylline on inflammatory changes and altered cell proliferation in chronic obstructive bronchitis.
    Cogo R; Castronuovo A
    Eur Rev Med Pharmacol Sci; 2000; 4(1-2):15-20. PubMed ID: 11409184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Corticosteroids].
    Löfdahl CG
    Rev Mal Respir; 1998 Sep; 15 Suppl 2():S42-4. PubMed ID: 9809343
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of ipratropium bromide on histamine-induced bronchoconstriction in subjects with chronic airway obstruction].
    Nannini LJ
    Medicina (B Aires); 2001; 61(3):262-6. PubMed ID: 11474870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tiotropium: a bronchodilator for chronic obstructive pulmonary disease.
    Somand H; Remington TL
    Ann Pharmacother; 2005 Sep; 39(9):1467-75. PubMed ID: 16030078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of salbutamol and ipratropium bromide on arterial blood gases in patients with stable COPD].
    Ozdemir T; Geçkin E; Oğüş C; Cilli A
    Tuberk Toraks; 2003; 51(2):132-7. PubMed ID: 15143418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic bronchitis. Choosing the optimal treatment.
    Griffith DE; Kronenberg RS
    Postgrad Med; 1993 Dec; 94(8):93-100. PubMed ID: 8248002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
    Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM
    Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effects of nebuliser treatment with berotec on external respiratory function, bronchial permeability, hemodynamics, acid-alkaline balance, oxygen saturation, and their circadian structure in elderly patients with chronic obstructive pulmonary disease].
    Zaslavskaia RM; Veklenko GV; Akhmetov KZh; Teĭblium MM
    Ter Arkh; 2004; 76(2):55-7. PubMed ID: 15106417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.